Preventive Medicine Doctors in Santa Barbara, CA Accepting Medicare

6 Preventive Medicine doctors found. Showing 1 - 6

Edward Gastaldo, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 812 Cheltenham Rd, Santa Barbara, CA 93105 Phone: 310-746-7323

Dr. David Howard Paul, M.D., PH.D. Preventive Medicine - Sports Medicine Medicare: Medicare Enrolled Practice Location: 2026 Cliff Dr, Suite 187, Santa Barbara, CA 93109 Phone: 805-699-6543

Dr. Rodney Romine Paragas, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2416 Castillo St, Ste. C, Santa Barbara, CA 93105 Phone: 805-569-8825

Steven Dosch, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761    Fax: 805-681-1768

Michael Feinberg, M.D. Preventive Medicine - Aerospace Medicine Medicare: Medicare Enrolled Practice Location: 1350 Arroyico Ln, Santa Barbara, CA 93108 Phone: 805-969-4117

Mark H Musicant, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 101 S Patterson Ave, Santa Barbara, CA 93111 Phone: 805-898-3311    Fax: 805-964-9645

News Archive

Siemens Medical pledges $200,000 to SIR Foundation's Discovery Campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Siemens Medical Solutions, a provider of imaging and laboratory diagnostic equipment and information technology and management consulting and services to health care customers, pledged $200,000, as a "Pioneer" Supporter.

Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.

Darunavir-ritonavir shows benefits for patients with HIV

Darunavir-ritonavir should be considered as a treatment option across the range of treatment-experienced patients with HIV infection, conclude Jose Madruga (Centro de Referencia e Treinamento DST/AIDS, Sao Paulao, Brazil) and colleagues in an Article in this week's issue of The Lancet.

Researchers develop best biologically based test for autism to date

Researchers at Harvard-affiliated McLean Hospital and the University of Utah have developed the best biologically based test for autism to date. The test was able to detect the disorder in individuals with high-functioning autism with 94 percent accuracy. The study will be published online the week of November 29th in Autism Research.

Read more Medical News

› Verified 2 days ago